PITT HOME | PACCM HOME | CONTACT US

 
 

UPDATED MARCH 2017:
The information currently found on this site is for the 2016 Lung Conference,
"Lung Immune Responses and Inflammation in Health and Disease."

Information for the 2018 Lung Conference is forthcoming.
SAVE THE DATE: October 4-5, 2018

Past Conferences

2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2006 | 2004 | 2003 | 2002 | ALL
 
 

2013 Summary | Flyer

The 2013 Pittsburgh International Lung Conference, entitled “Acute and Chronic Lung Infections:  Novel Pathogens, Diagnostics, and Therapeutics” was held on October 17-18, 2013 at the University Club on the University of Pittsburgh campus. The objective of the 2013 conference was to bring together leading pulmonary and infectious diseases clinical and basic scientists, practicing clinicians, industry leaders and trainees for two days of talks and discussions focusing on pulmonary infections. Information derived from rapidly emerging diagnostic and therapeutic modalities as well as the role of infections in chronic lung diseases make this a topic of significant interest to the pulmonary and infectious diseases communities.

Pulmonary infections are a leading cause of mortality worldwide.  Lung infections are also a common cause of morbidity and mortality in the expanding population of patients who are immunosuppressed secondary to organ transplantation or chronic HIV infection.  The role that infections play in typically non-infectious lung diseases such as chronic obstructive pulmonary disease and asthma demonstrate that the impact of lung pathogens extends beyond acute pneumonia.  Despite the global importance of lung infections, development of new antibiotics, vaccines, and novel therapeutics has been slow.  Emerging technologies are rapidly expanding diagnostic approaches and establishing new areas of research such as the role of the lung microbiome in pulmonary diseases. 

Among the speakers were world-class leaders in drug and vaccine development, treatment of resistant organisms, and public health and industry leaders. In addition, talks featured cutting-edge science in microbiome studies and emerging and resistant pathogens that provided a unique blend of state-of-the-art information with broad appeal to the scientific and greater patient-oriented community. 

The program included six plenary sessions and two poster sessions on stimulating topics, such as:

A poster reception followed the scientific sessions on Friday, providing an excellent forum for researchers to present their cutting-edge science.

Featured keynote speaker at the Banquet Dinner on Friday evening was Donna E. Shalala, PhD, President of the University of Miami and former Secretary of Health and Human Services.  Dr. Shalala spoke on Health Care Delivery and focused on the changing accessibility for individual health care.

Each session ended with a panel discussion, allowing an opportunity for questions and further interaction among participants. 

Distinguished speakers included:

*Denotes Organizing Committee Member